Form D · Pharmaceuticals
Mind Medicine (MindMed) Inc.
New York, NY · CIK 0001813814
Offering snapshot reported May 5, 2025 · SEC filing
- Reported sold
- $7M Offering amount: $7M
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Aug 11, 2023 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 5, 2025 | Initial | $7,000,000 | No comparison | 1 | SEC filing |
| Mar 18, 2024 | Initial | $75,000,000 | No comparison | 2 | SEC filing |
| Jan 20, 2021 | Initial | $499,618 | No comparison | 1 | SEC filing |
| Dec 22, 2020 | Initial | $78,268 | No comparison | 1 | SEC filing |
| Nov 13, 2020 | Initial | $247,705 | No comparison | 1 | SEC filing |
| Jun 8, 2020 | Initial | $468,248 | No comparison | 2 | SEC filing |
Offering details
- Securities
- Equity, Other
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-545248
Term loan, $7,000,000 of which is convertible into common shares.
Term loan, $7,000,000 of which is convertible into common shares.
Source: Form D, filed May 5, 2025. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Robert Barrow | Director, Executive |
| Suzanne Bruhn | Director |
| Roger Crystal | Director |
| Perry Dellelce | Director |
| Stanley Glick | Director |
| Schond Greenway | Executive |
| David Gryska | Director |
| Stephen Hurst | Director, Executive |
| Daniel Karlin | Executive |
| Andreas Krebs | Director |
| Carrie Liao | Executive |
| Bruce Linton | Director |
| Brigid Makes | Director |
| Jamon Alexander Rahn | Director, Executive |
| Jamon Alexander Rahn | Director, Executive |
| Mark R. Sullivan | Executive |
| Carol A. Vallone | Director |
| Miri Halperin Wernli | Executive |
| Miriam Halperin Wernli | Director, Executive |
| Miriam Halperin Wernli | Director, Executive |
| Matt Wiley | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
One World Trade Center Suite 8500
New York, NY, 10007
New York, NY, 10007